Tandem Diabetes Care (TNDM) Common Equity (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Common Equity came in at $132.4 million in Q1 2026, down 14.74% YoY from $155.3 million in Q1 2025, and down 14.67% on a QoQ basis from $155.2 million in Q4 2025.
Tandem Diabetes Care (TNDM) Common Equity (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Common Equity data on file, last reported at $132.4 million in Q1 2026.
- Quarterly Common Equity fell 14.74% year-over-year to $132.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $132.4 million (down 14.74% YoY) and the FY2025 annual result came in at $155.2 million, down 41.02% from the prior year.
- Common Equity eased to $132.4 million in Q1 2026, from $155.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $449.6 million in Q2 2022 to a low of $132.4 million in Q1 2026.
- A 5-year average of $278.3 million and a median of $263.1 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity soared 39.55% — and 2025, when it plunged 44.06%.
- Tracing TNDM's Common Equity over 5 years: stood at $439.9 million in 2022, then slipped by 28.71% to $313.6 million in 2023, then decreased by 16.11% to $263.1 million in 2024, then slumped by 41.02% to $155.2 million in 2025, then fell by 14.67% to $132.4 million in 2026.
- The last three Common Equity figures came in at $132.4 million (Q1 2026), $155.2 million (Q4 2025), and $133.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn | 130.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 130.39 Mn |
| Mar 31, 2026 | 132.40 Mn |
| Dec 31, 2025 | 155.17 Mn |
| Sep 30, 2025 | 132.97 Mn |
| Jun 30, 2025 | 133.28 Mn |
| Mar 31, 2025 | 155.29 Mn |
| Dec 31, 2024 | 263.10 Mn |
| Sep 30, 2024 | 237.71 Mn |
| Jun 30, 2024 | 233.88 Mn |
| Mar 31, 2024 | 243.06 Mn |
| Dec 31, 2023 | 313.63 Mn |
| Sep 30, 2023 | 314.00 Mn |
| Jun 30, 2023 | 329.23 Mn |
| Mar 31, 2023 | 338.75 Mn |
| Dec 31, 2022 | 439.95 Mn |
| Sep 30, 2022 | 421.82 Mn |
| Jun 30, 2022 | 449.58 Mn |
| Mar 31, 2022 | 437.38 Mn |
| Dec 31, 2021 | 433.11 Mn |
| Sep 30, 2021 | 389.65 Mn |